Skip to main content

Table 7 NPI scores by visit

From: Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial

 

BI 425809

Placebo

2 mg QD

5 mg QD

10 mg QD

25 mg QD

Baseline, mean (SD)

8.09 (9.99)

7.36 (9.03)

8.50 (10.01)

8.03 (10.91)

8.07 (8.11)

Week 12, mean (SD)

7.85 (11.97)

6.28 (10.12)

9.34 (11.59)

7.85 (10.42)

7.40 (8.70)

Change from baseline at week 12, mean (SD)

− 0.53 (8.20)

− 0.84 (9.49)

1.33 (7.74)

− 0.10 (7.93)

− 0.90 (7.03)

  1. NPI neuropsychiatric inventory score, SD standard deviation, QD once daily